Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Deep Medicine from Beveren-Kruibeke-Zwijndrecht, company number BE0772322413, closed financial year 2025 with a result of € -27,919 after tax. For that financial year Deep Medicine recorded a gross margin of € -23,625 and equity of € -59,830. Compared with financial year 2024, the result moved from € -50,565 to € -27,919. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ -59,830
▼ € 27,919 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,919
▲ 45 % less loss than in 2024
Profit after tax over the fiscal year.
€ 2,965
▼ 85% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -67,737.
Debts at end 2025
€ 34,079
▼ 61% vs 2024
Loans from banks and other lenders, long and short.
€ 15,281
▲ € 12,852 vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -14,579 | € -12,633 | € 6,388 | € -23,625 | ▼ € 30,013 |
| Profit after taxes | € -63,813 | € -66,427 | € -50,565 | € -27,919 | ▲ € 22,645 |
| Equity | € 85,080 | € 18,654 | € -31,911 | € -59,830 | ▼ € 27,919 |
| Total debts | € 148,453 | € 216,124 | € 228,857 | € 237,699 | ▲ 4% |
| Cash | € 2,020 | € 3,612 | € 19,222 | € 2,965 | ▼ 85% |
| Retained profit | € 77,173 | € 10,747 | € -39,818 | € -67,737 | ▼ € 27,919 |
| Bank debt | € 84,215 | € 85,900 | € 87,659 | € 34,079 | ▼ 61% |
| Balance sheet total | € 233,534 | € 234,778 | € 196,946 | € 177,869 | ▼ 10% |
Key figures of Deep Medicine, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Deep Medicine?
What happened at Deep Medicine in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 27,919. Source: NBB ↗
- Perpetuum Ventures NV became a director. NBB
- Cobagest CommV became a director. NBB
- Tom De Bast stepped down as director. NBB
- James Troch stepped down as director. NBB
- New establishment in Oud-Turnhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,813 loss in 2022 to € 27,919 loss in 2025.
A new publication or filing at Deep Medicine? We notify you, reason included.
Follow Deep MedicineDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Deep Medicine are Perpetuum Ventures NV and Cobagest CommV. The same people are also behind Venture Campus Management. Cobagest CommV is also behind VENTURE CAMPUS.
Directors
According to the 2025 annual accounts
Director · represented by James Troch
Also active at: Venture Campus Management
since 2026
Director · represented by Tom De Bast
Also active at: VENTURE CAMPUS, Venture Campus Management
since 2026
· until 2026
James Troch
Director
Also active at: DIGITAL DARWIN, VENTURE CAMPUS, 247 Energy, Perpetuum Ventures, Asterion Therapeutics, Perpetuum CropScience, 247 Alpha, d2 benelux +1 more
· until 2026
Establishments
Establishment units
Physical locations of this company
Schaarbeekstraat(MEL) 20E box 11
9120 Beveren-Kruibeke-Zwijndrecht
Guldenweg 7
2360 Oud-Turnhout
Active since 6 August 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →MARCEL DE VOS & C°
€ -1.1 million gross margin · 2025
CINERGY EUROPE
€ 4,933 gross margin · 2025
247 Energy same network
€ 260,525 gross margin · 2025
Cartière
€ 683,067 gross margin · 2025
247 Alpha same network
€ 205,802 gross margin · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0772.322.413
- VAT number
- BE 0772.322.413
- Registered office
- Schaarbeekstraat(MEL) 20E bus 11, 9120 Beveren-Kruibeke-Zwijndrecht
- Names & denominations
- Deep Medicine
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 August 2021
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Organisatie van congressen en beurzen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige gespecialiseerde wetenschappelijke en technische activiteiten